Clinical trials
Obesity, Abdominal trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laval University | 2 |
| McMaster University | 2 |
| Queen's University | 2 |
| Daren K. Heyland | 1 |
| François Lellouche | 1 |
| Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | 1 |
| Marja-Riitta Taskinen | 1 |
| University of Guelph | 1 |
| Université de Sherbrooke | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity, Abdominal | 12 |
| Cardiovascular Diseases | 4 |
| Obesity | 4 |
| Diabetes Mellitus | 3 |
| Hypertriglyceridemia | 2 |
| Metabolic Syndrome | 2 |
| Diabetes Mellitus, Type 1 | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dysbiosis | 1 |
| Fatty Liver | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.